PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Wang, L.* ; Zhang, Y.* ; Liu, X.* ; Zhao, X.* ; Ouyang, Y.* ; Qiu, G.* ; Lv, W.* ; Zheng, F.* ; Wang, Q.* ; Lu, X.* ; Peng, X.* ; Wu, T.* ; Lehmann, R. ; Wang, C.* ; Jia, W.* ; Xu, G.*

Metabolite triplet in serum improves the diagnostic accuracy of prediabetes and diabetes screening.

J. Proteome Res. 20, 1005-1014 (2021)
DOI PMC
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Large-scale population screenings are not feasible by applying laborious oral glucose tolerance tests, but using fasting blood glucose (FPG) and glycated hemoglobin (HbA1c), a considerable number of diagnoses are missed. A novel marker is urgently needed to improve the diagnostic accuracy of broad-scale diabetes screening in easy-to-collect blood samples. In this study, by applying a novel knowledge-based, multistage discovery and validation strategy, we scaled down from 108 diabetes-associated metabolites to a diagnostic metabolite triplet (Met-T), namely hexose, 2-hydroxybutyric/2-hydroxyisobutyric acid, and phenylalanine. Met-T showed in two independent cohorts, each comprising healthy controls, prediabetic, and diabetic individuals, distinctly higher diagnostic sensitivities for diabetes screening than FPG alone (>79.6 vs <68%). Missed diagnoses decreased from >32% using fasting plasma glucose down to <20.4%. Combining Met-T and fasting plasma glucose further improved the diagnostic accuracy. Additionally, a positive association of Met-T with future diabetes risk was found (odds ratio: 1.41; p = 1.03 × 10-6). The results reveal that missed prediabetes and diabetes diagnoses can be markedly reduced by applying Met-T alone or in combination with FPG and it opens perspectives for higher diagnostic accuracy in broad-scale diabetes-screening approaches using easy to collect sample materials.
Impact Factor
Scopus SNIP
Altmetric
4.466
1.016
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Diabetes Screening ; Liquid Chromatography-mass Spectrometry ; Metabolite Markers ; Metabolomics ; Prediction Of Diabetes Risk; Impaired Fasting Glucose; Plasma-glucose; Metabolomics; Risk; Hyperglycemia; Biomarkers; Tolerance; Fructose; China; A1c
Sprache englisch
Veröffentlichungsjahr 2021
Prepublished im Jahr 2020
HGF-Berichtsjahr 2020
ISSN (print) / ISBN 1535-3893
e-ISSN 1535-3907
Zeitschrift Journal of Proteome Research
Quellenangaben Band: 20, Heft: 1, Seiten: 1005-1014 Artikelnummer: , Supplement: ,
Verlag American Chemical Society (ACS)
Verlagsort 1155 16th St, Nw, Washington, Dc 20036 Usa
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Diabetes Research and Metabolic Diseases (IDM)
POF Topic(s) 90000 - German Center for Diabetes Research
Forschungsfeld(er) Helmholtz Diabetes Center
PSP-Element(e) G-502400-001
Förderungen innovation program of science and research from the DICP, CAS
National Key Research and Development Program of China
key foundation from the National Natural Science Foundation of China
National Natural Science Foundation of China
DOI 10.1021/acs.jproteome.0c00786
WOS ID WOS:000605145400087
Scopus ID 85099305964
PubMed ID 33347754
Erfassungsdatum 2021-01-12
[➜Korrektur melden]